ID: ALA2268813

Max Phase: Preclinical

Molecular Formula: C16H17NO3

Molecular Weight: 271.32

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(CNC(=O)c2ccccc2)cc1OC

Standard InChI:  InChI=1S/C16H17NO3/c1-19-14-9-8-12(10-15(14)20-2)11-17-16(18)13-6-4-3-5-7-13/h3-10H,11H2,1-2H3,(H,17,18)

Standard InChI Key:  ODSOSJXLGRPHPR-UHFFFAOYSA-N

Associated Targets(non-human)

NADH-ubiquinone oxidoreductase chain 1 124 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 271.32Molecular Weight (Monoisotopic): 271.1208AlogP: 2.63#Rotatable Bonds: 5
Polar Surface Area: 47.56Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.46CX LogD: 2.46
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.91Np Likeness Score: -0.87

References

1. Satoh T, Miyoshi H, Sakamoto K, Iwamura H..  (1996)  Comparison of the inhibitory action of synthetic capsaicin analogues with various NADH-ubiquinone oxidoreductases.,  1273  (1): [PMID:8573592] [10.1016/0005-2728(95)00131-x]

Source